BIOMAT Database Logo BIOMAT Database Logo

[Prognosis in silicotuberculosis]. 1970

R Giura

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000636 Aminosalicylic Acids A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions. Acids, Aminosalicylic
D012830 Silicotuberculosis Pulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with silicosis. Silicotuberculoses
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa

Related Publications

R Giura
[The prognosis of resection in silicotuberculosis of the lung].
July 1962, Thoraxchirurgie,
R Giura
[Silicotuberculosis. Considerations on its frequency, prognosis and prevention].
October 1965, Jornal do medico,
R Giura
Silicotuberculosis.
May 1960, Canadian Medical Association journal,
R Giura
[Silicotuberculosis].
October 1959, Minerva medica,
R Giura
[Silicotuberculosis].
June 1963, La Riforma medica,
R Giura
[Silicotuberculosis].
January 1961, Ftiziologia,
R Giura
[SILICOTUBERCULOSIS].
January 1963, Trudy Leningradskogo sanitarno-gigienicheskogo meditsinskogo instituta,
R Giura
[Silicotuberculosis].
January 1960, Izvestiia na meditsinskite instituti. [Bulletin des instituts de medecine]. Bulgarska akademiia na naukite. Otdelenie za biologicheski i meditsinski nauki,
R Giura
[Silicotuberculosis].
January 1951, Schweizerische Zeitschrift fur Tuberkulose. Revue suisse de la tuberculose. Rivista svizzera della tubercolosi,
R Giura
[Silicotuberculosis].
January 1978, Godisen zbornik na Medicinskiot fakultet vo Skopje,
Copied contents to your clipboard!